Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Our mission/goal
Our goal is to provide specialized high-tech medical care for children with chronic diseases, based on the latest data of scientific and clinical potential of the professional community of highly experienced experts in pediatric healthcare.
Publications 2014
  • 1.       Franz DN, Belousova E, Sparagana S, Bebin EM  et al. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol. 2014 Dec;15(13):1513-20. Impact factor 24.725
  • 2.       Iourov I.Y., Vorsanova S.G., Yurov Y.B. In silico molecular cytogenetics: a bioinformatic approach to prioritization of candidate genes and copy number variations for basic and clinical genome research // Molecular Cytogenetics. 2014.- 7:98. - 10 p. Impact factor 2.66
  • 3.       Iourov I.Y., Vorsanova S.G., Liehr T., Yurov Y.B. Mosaike im Gehirn des Menschen: Diagnostische relevanz in der zukunft // Medizinische genetic. 2014. –Vol.26. – N3. – P.342-345. Impact factor 0.222
  • 4.       Kushnareva M., Vetrova E., Dementyeva G. The use of intravenous immunoglobulins in premature newborn children in hardware lung ventilation. The use of intravenous immunoglobulins in premature newborn children in hardware lung ventilation // International journal of medical sciences (Sciences MED) 2014; 5 (2): 23-25. Impact factor 1.62
  • 5.       John C Kingswood, Paolo Bruzzi, Elena Belousova, et al. TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex // Orphanet Journal of Rare Diseases. 2014, 9:182. 2014, 9:182. Impact factor 3.96
  • 6.       Kobrinskii B.A. Argumentation systems: Medical applications. //Automatic Documentation and Mathematical Linguistics. 2014. Vol.48. Iss.2. P. 78-80.
  • 7.       Iourov I.U., Vorsanova S.G., Kurinnaya O.S., Yurov Y.B. An Interstitial Deletion at 10q26.2q26.3. //Case Reports in Genetics Vol. 2014. Article ID 505832. 3 pages
  • 8.       A. Oksuzyan, M. Shkolnikova, J. W. Vaupel, K. Christensen, V. M. Shkolnikov. Sex differences in health and mortality in Moscow and Denmark. //Eur J Epidemiol // Publessed on-line. 26/03/2014. Impact factor 5.147
  • 9.       M.Shkolnikova, V. M. Shkolnikov. Recalibration of the SCORE risk chart for the Russian population. //Eur J Epidemiol// Publessed on-line. 02/09/2014. Impact factor 5.147
  • 10.   Alla E. Sipyagina, Larisa S. Baleva, Nataliya M. Karakhan, Vladimir S. Sukhorukov, Milyausha Tagirova. Role of Postradiation Genome Instability in Evaluating the Development of Radiation-Determined Pathology in Children after the Chernobyl Accident and Investigation Perspectives. //Advanced Materials Research. 2014. Vol.1051. P. 322-325. Impact factor 0.3
  • 11.   Elena D. Belousova*, Ivan I. Iourov, Irina V. Shulyakova and Oxana Thishkova. Detected by Array CGH in Patient with Microcephaly and Early Epileptic Encephalopathy with Infantile Spasms //Journal of Neurology and Epidemiology. 2014, 1, 00-00 1E-ISSN: 2309-6179/14© 2014 Savvy Science Publisher Clinical Report: CNVs
  • 12.   Elena D. Belousova, Ivan I. Iourov, Irina V. Shulyakova and Oxana N. Tsyshkova. Clinical Report: CNVs (Deletions of 3p24.1, 6p12.2; 12q24.22) Detected by Array CGH in Patient with Microcephaly and Early Epileptic Encephalopathy with Infantile Spasms. //Journal of Neurology and Epidemiology. 2014; 2(1)50-54
  • 13.   J. Chris Kingswood,, Sergiusz Jozwiak, Elena D. Belousova et al. The effect of everolimus on renal angiomyolipomain patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1. //Nephrol Dial Transplant. 2014. №29. P.1203–1210. Impact factor 3.396.
  • 14. Francesco Lagona, Dmitri Jdanov and Maria Shkolnikova Latent time-varying factors in longitudinal analysis: a linear mixed hidden Markov model for heart rates Statistics and medicine Volume 33, Issue 23, 15 October 2014, Pages: 4116–4134. Impact factor 2.037.
All information contained on this site are for informational purposes only. The information provided on the website is not exhaustive.